Avilar Therapeutics

Waltham, United States

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

Feb 2023

Seed

Biotechnology Medical Pharmaceutical

Top Investors

RA Capital ManagementSanofi VenturesMedical Excellence CapitalAstellas Venture Management

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avilar Therapeutics

Who are Avilar Therapeutics's investors?

Avilar Therapeutics's investors include RA Capital Management, Sanofi Ventures, Medical Excellence Capital, Astellas Venture Management.

Where is Avilar Therapeutics headquartered?

Avilar Therapeutics is headquartered in Waltham, United States.

What does Avilar Therapeutics do?

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

What stage is Avilar Therapeutics at?

Avilar Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 16, 2023.

MLA

"Avilar Therapeutics — Funding & Investors." VCBacked, February 16, 2023, https://www.vcbacked.co/company/avilar-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). Avilar Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/avilar-therapeutics

Wikipedia (cite web)

{{cite web |title=Avilar Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avilar-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 16, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.